Amneal Pharmaceuticals, Inc. (AMRX)
17.44
-0.43
(-2.41%)
USD |
NASDAQ |
Sep 04, 16:00
17.46
+0.02
(+0.09%)
After-Hours: 20:00
Amneal Pharmaceuticals SG&A Expense (TTM) : 571.86M for June 30, 2026
SG&A Expense (TTM) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical SG&A Expense (TTM) Data
| Date | Value |
|---|---|
| June 30, 2026 | 571.86M |
| March 31, 2026 | 547.40M |
| December 31, 2025 | 526.83M |
| September 30, 2025 | 509.06M |
| June 30, 2025 | 489.93M |
| March 31, 2025 | 482.13M |
| December 31, 2024 | 476.44M |
| September 30, 2024 | 456.75M |
| June 30, 2024 | 451.07M |
| March 31, 2024 | 440.17M |
| December 31, 2023 | 429.68M |
| September 30, 2023 | 422.83M |
| June 30, 2023 | 409.90M |
| March 31, 2023 | 403.13M |
| December 31, 2022 | 399.70M |
| September 30, 2022 | 394.77M |
| June 30, 2022 | 386.09M |
| March 31, 2022 | 373.44M |
| December 31, 2021 | 365.50M |
| September 30, 2021 | 352.97M |
| June 30, 2021 | 344.69M |
| March 31, 2021 | 339.48M |
| December 31, 2020 | 326.73M |
| September 30, 2020 | 316.12M |
| June 30, 2020 | 296.80M |
| Date | Value |
|---|---|
| March 31, 2020 | 283.14M |
| December 31, 2019 | 289.60M |
| September 30, 2019 | 289.75M |
| June 30, 2019 | 304.03M |
| March 31, 2019 | 289.75M |
| December 31, 2018 | 230.44M |
| September 30, 2018 | 183.16M |
| June 30, 2018 | 132.53M |
| March 31, 2018 | 106.46M |
| December 31, 2017 | 81.34M |
| September 30, 2017 | 111.96M |
| June 30, 2017 | 139.56M |
| March 31, 2017 | 157.53M |
| December 31, 2016 | 201.83M |
| September 30, 2016 | 200.76M |
| June 30, 2016 | 192.02M |
| March 31, 2016 | 195.42M |
| December 31, 2015 | 201.29M |
| September 30, 2015 | 186.98M |
| June 30, 2015 | 179.56M |
| March 31, 2015 | 164.07M |
| December 31, 2014 | 139.39M |
| September 30, 2014 | 126.51M |
| June 30, 2014 | 115.59M |
| March 31, 2014 | 116.05M |
SG&A Expense (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
SG&A Expense (TTM) Benchmarks
| Liquidia Corp. | 192.66M |
| Eli Lilly & Co. | 12.24B |
| Viatris, Inc. | 3.981B |
| Pfizer Inc. | 13.72B |
| Harmony Biosciences Holdings, Inc. | 272.47M |